Burning Rock Biotech Shareholders’ Equity Growth & History (BNR)
Burning Rock Biotech's shareholders’ equity was $76.5M for fiscal 2025.
View full Burning Rock Biotech company overviewBurning Rock Biotech annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $76.5M | −$3.0M | −3.81% |
| 2024 | 2024-12-31 | $79.6M | −$28.7M | −26.48% |
| 2023 | 2023-12-31 | $108.2M | −$59.7M | −35.56% |
| 2022 | 2022-12-31 | $167.9M | −$121.6M | −42.00% |
| 2021 | 2021-12-31 | $289.6M | −$81.5M | −21.96% |
| 2020 | 2020-12-31 | $371.0M | — | — |
Burning Rock Biotech quarterly shareholders’ equity
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $76.5M | −$3.0M | −3.81% |
| Q4 2024 | 2024-12-31 | $79.6M | −$28.7M | −26.48% |
| Q4 2023 | 2023-12-31 | $108.2M | −$59.7M | −35.56% |
| Q4 2022 | 2022-12-31 | $167.9M | −$121.6M | −42.00% |
| Q2 2022 | 2022-06-30 | $213.8M | — | — |
| Q4 2021 | 2021-12-31 | $289.6M | −$81.5M | −21.96% |
| Q4 2020 | 2020-12-31 | $371.0M | — | — |
Burning Rock Biotech shareholders’ equity trends
Over the last five fiscal years, Burning Rock Biotech's shareholders’ equity decreased from $371.0M to $76.5M, a change of −$294.5M. The latest reported quarter, Q4 2025, shows $76.5M.
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burning Rock Biotech source filings ↗